Infectious Diseases

pharma-news-for-ge-optellum-therapixel-ocugen-blueprint

Notizia - Recent Pharma, Healthcare and Biotech Happenings

GE Healthcare-Optellum’s collaboration; Ocugen’s Covid-19 vaccine trial; Blueprint to acquire Lengo Therapeutics; Therapixel’s Mammoscreen

GE Healthcare, Optellum collaborate for AI-based lung cancer diagnosis GE Healthcare has collaborated with Optellum to progress precision diagnosis and lung cancer treatment with artificial intelligence. The partnership is zeroed in on helping healthcare providers to evaluate the malignancy of a lung nodule and a suspicious lesion that may be benign or cancerous. Optellum is engaged in proffering AI decision support for the early diagnosis and optimal lung cancer treatment, while GE Healthcare is a major player in medical imaging solutions. The Virtual Nodule Clinic, the AI-powered clinical decision support software developed by Optellum, enables recogniti...

Explore More...

recent-pharma-news-and-updates-for-novartis-gsk-exact-sciences-eqrx

Novartis taps Molecular Partners to combat COVID-19; GSK culls phase 2 asthma drug; Exact Sciences acquires Thrive for $ 2.15 B; EQRx-CStone’s deal for checkpoint inhibitors

Pharma news for Bayer, Novartis, Forma, AskBio

Bayer eyes AskBio’s Gene Therapies; Novartis’ Iptacopan; Forma’s IDH1-Mutated AML Therapy; EpicGenetics teams up with Mayo Clinic

GSK’s RSV vaccine; SparingVision’s interest in gene therapy; InCarda’s raise; BridgeBio’s R&D deal

Venclexta full approval; PBP1510 Orphan Status; Roche/ Genesis collab; Immunomodulators for COVID-19

recent-pharma-news-and-updates-for-moderna-pfizer-myovant-alnylam

Brain’s immune cells research update; Moderna’s COVID-19 vaccine; Pfizer funnels $200 M into CStone; Myovant’s relugolix falls short in metastatic prostate cancer; Alnylam’s lumasiran phase 3 result

COVID-19 Vaccine News-Inovio, AZ, J&J; Latest HES Rare Disease News

Inovio’s COVID vaccine trial On-hold; Appeal to Pfizer; XtalPi’s massive raise; GSK Nucala’s HES approval; J&J’s COVID vaccine

recent-pharma-happenings-for-eli-lilly-aziyo-biologics-bms

Lilly’s COVID-19 antibody reduces hospitalization rate; Tiny biologic drug to combat COVID-19; Aziyo Biologics files for $57.5 M IPO; BMS exercises option on Obsidian’s CD40L cell therapy

AZ corona Vaccine trial | Merck and Gilead Deal

While AZ resumes its COVID-19 vaccine trial in the UK; Merck and Gilead are busy making sizeable Breast cancer deals

recent-pharma-happenings-for-pfizer-biontech-oncoimmune-recursion

Pfizer-BioNTech COVID-19 vaccine trials; OncoImmune raises $56 M; Recursion Pharma nets $239 M; Breast cancer research updates

Pharma news for Bayer Verona Cycle Pharma

Cycle Pharmaceuticals’ USD 25M Debt Financing; Bayer’s Phase IV REPLACE Trial; Verona’s Pilot Study with pMDI Ensifentrine in COVID Patients

recent-pharma-happenings-for-nestle-gsk-astrazeneca

Nestle to acquire Aimmune Therapeutics; Vir Bio & GSK’s COVID-19 monoclonal antibody therapy; AstraZeneca’s Farxiga scores goal in Phase III CDK trial

recent-pharma-news-and-updates-for-moderna-freenome

Moderna’s COVID-19 vaccine trial; Freenome secures $270 M; CRISPR treats obesity in mice; Breast cancer research updates

Novartis’s Spartalizumab Combo Stumbles; Union Therapeutics Doses In COVID-19 Trial; Yumanity To Merge With Proteostasis

recent-pharma-news-and-updates-for-gilead-roche-celleron-f2g

Gilead’s remdesivir trials; F2G raises $60.8M; Cancer immunotherapy research updates; Celleron gains rights to Roche’s cancer drug